Literature DB >> 12100369

Hepatocyte growth factor in cerebrospinal fluid in neurologic disease.

Y Tsuboi1, K Kakimoto, H Akatsu, Y Daikuhara, T Yamada.   

Abstract

OBJECTIVE: To investigate hepatocyte growth factor (HGF) concentration in cerebrospinal fluid (CSF) in neurologic disease.
MATERIALS AND METHODS: We determined CSF concentration of HGF with human-HGF-specific enzyme-linked immunosorbent assays (ELISA) in 121 patients: Alzheimer's disease (AD) (33), amyotrophic lateral sclerosis (ALS) (10), Parkinson's disease (PD) (5), progressive supranuclear palsy (PSP) (3), spinocerebellar degeneration (7), acute disseminating encephalomyelitis (ADEM) (6), human T-lymphotropic virus-1 (HTLV-1)-associated myelopathy (HAM) (6), multiple sclerosis (MS) (7), aseptic meningitis (AM) (12), and peripheral neuropathy and myopathy as control diseases (32).
RESULTS: HGF concentrations in CSF were significantly higher with diseases of the central nervous system (CNS) than control diseases and were slightly higher with AD than other neurodegenerative diseases. Values were highest with ADEM but decreased during corticosteroid treatment. We found no relationship between HGF in CSF and CSF cells or protein, immunoglobulin index, or Q albumin.
CONCLUSION: It is suggested that high concentrations of HGF in CSF may be partially related to CNS pathology, especially to demyelinating disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12100369     DOI: 10.1034/j.1600-0404.2002.01125.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  10 in total

1.  Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells.

Authors:  Mahdia Benkhoucha; Marie-Laure Santiago-Raber; Gregory Schneiter; Michel Chofflon; Hiroshi Funakoshi; Toshikazu Nakamura; Patrice H Lalive
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-23       Impact factor: 11.205

2.  Prenatal expression of MET receptor tyrosine kinase in the fetal mouse dorsal raphe nuclei and the visceral motor/sensory brainstem.

Authors:  Hsiao-Huei Wu; Pat Levitt
Journal:  Dev Neurosci       Date:  2013-03-20       Impact factor: 2.984

3.  Specific Connectivity and Unique Molecular Identity of MET Receptor Tyrosine Kinase Expressing Serotonergic Neurons in the Caudal Dorsal Raphe Nuclei.

Authors:  Ryan J Kast; Hsiao-Huei Wu; Piper Williams; Patricia Gaspar; Pat Levitt
Journal:  ACS Chem Neurosci       Date:  2017-05-01       Impact factor: 4.418

4.  Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand?

Authors:  Alexandre Henriques; Claudia Pitzer; Armin Schneider
Journal:  Front Neurosci       Date:  2010-06-11       Impact factor: 4.677

5.  Interferon-β induces hepatocyte growth factor in monocytes of multiple sclerosis patients.

Authors:  Nicolas Molnarfi; Mahdia Benkhoucha; Kristbjörg Bjarnadóttir; Catherine Juillard; Patrice H Lalive
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

6.  Importance of the brain Angiotensin system in Parkinson's disease.

Authors:  John W Wright; Joseph W Harding
Journal:  Parkinsons Dis       Date:  2012-11-07

7.  Hepatocyte growth factor level in cerebrospinal fluid as an additional marker in patient with drug-resistant streptococcus pneumoniae meningitis treated with linezolid.

Authors:  Hung-Chin Tsai; Yao-Shen Chen; Susan Shin-Jung Lee; Yu-Hung Lin; Shue-Ren Wann; Cheng Len Sy; Yung-Ching Liu
Journal:  Clin Med Case Rep       Date:  2008-05-27

8.  Plasma biomarkers discriminate clinical forms of multiple sclerosis.

Authors:  Marta Tejera-Alhambra; Armanda Casrouge; Clara de Andrés; Ansgar Seyfferth; Rocío Ramos-Medina; Bárbara Alonso; Janet Vega; Lidia Fernández-Paredes; Matthew L Albert; Silvia Sánchez-Ramón
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

9.  Associations of the cerebrospinal fluid hepatocyte growth factor with Alzheimer's disease pathology and cognitive function.

Authors:  Li-Jing Zhao; Zuo-Teng Wang; Ya-Hui Ma; Wei Zhang; Qiang Dong; Jin-Tai Yu; Lan Tan
Journal:  BMC Neurol       Date:  2021-10-06       Impact factor: 2.474

Review 10.  From Multi-Omics Approaches to Precision Medicine in Amyotrophic Lateral Sclerosis.

Authors:  Giovanna Morello; Salvatore Salomone; Velia D'Agata; Francesca Luisa Conforti; Sebastiano Cavallaro
Journal:  Front Neurosci       Date:  2020-10-30       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.